Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron F Carlin

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Biosensors & Bioelectronics|March 20, 2021
Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometerNaveen K Singh, Partha Ray, Aaron F Carlin, et al.
Analytical Chemistry|February 8, 2023
Protease-Responsive Potential-Tunable AIEgens for Cell Selective Imaging of TMPRSS2 and Accurate Inhibitor ScreeningYong Cheng, Alex E Clark, Wonjun Yim, et al.
Angewandte Chemie (International Ed. in English)|December 10, 2021
A Dual-Color Fluorescent Probe Allows Simultaneous Imaging of Main and Papain-like Proteases of SARS-CoV-2-Infected Cells for Accurate Detection and Rapid Inhibitor ScreeningYong Cheng, Raina M Borum, Alex E Clark, et al.
Msystems|January 25, 2022
Decoding Transcription Regulatory Mechanisms Associated with <i>Coccidioides immitis</i> Phase Transition Using Total RNASascha H Duttke, Sinem Beyhan, Rajendra Singh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2022
Virologic and Immunologic Characterization of Coronavirus Disease 2019 Recrudescence After Nirmatrelvir/Ritonavir TreatmentAaron F Carlin, Alex E Clark, Antoine Chaillon, et al.
The EMBO Journal|September 18, 2020
Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterolShaobo Wang, Wanyu Li, Hui Hui, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2023
PCIF1-mediated deposition of 5'-cap <i>N</i><sup>6</sup>,2'-<i>O</i>-dimethyladenosine in ACE2 and TMPRSS2 mRNA regulates susceptibility to SARS-CoV-2 infectionLingling Wang, Shaobo Wang, Lujing Wu, et al.
Open Forum Infectious Diseases|April 25, 2023
Neutralizing Antibody Responses After Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 and BA.2.12.1 Infection Do Not Neutralize BA.4 and BA.5 and Can Be Blunted by Nirmatrelvir/Ritonavir TreatmentAaron F Carlin, Alex E Clark, Aaron F Garretson, et al.
Viruses|May 25, 2024
Design and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid Protein to Validate the Viral Quality Assurance PanelsPartha Ray, Melissa Ledgerwood-Lee, Howard Brickner, et al.
Clinical Case Reports|May 3, 2021
Response to pegylated interferon in a COVID-19-positive elderly woman with primary myelofibrosis treated with ruxolitinibArthur E Frankel, Renuka Reddy, Kayla R DeSuza, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Biosensors & Bioelectronics|March 20, 2021
Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometerNaveen K Singh, Partha Ray, Aaron F Carlin, et al.
Analytical Chemistry|February 8, 2023
Protease-Responsive Potential-Tunable AIEgens for Cell Selective Imaging of TMPRSS2 and Accurate Inhibitor ScreeningYong Cheng, Alex E Clark, Wonjun Yim, et al.
Angewandte Chemie (International Ed. in English)|December 10, 2021
A Dual-Color Fluorescent Probe Allows Simultaneous Imaging of Main and Papain-like Proteases of SARS-CoV-2-Infected Cells for Accurate Detection and Rapid Inhibitor ScreeningYong Cheng, Raina M Borum, Alex E Clark, et al.
Msystems|January 25, 2022
Decoding Transcription Regulatory Mechanisms Associated with <i>Coccidioides immitis</i> Phase Transition Using Total RNASascha H Duttke, Sinem Beyhan, Rajendra Singh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2022
Virologic and Immunologic Characterization of Coronavirus Disease 2019 Recrudescence After Nirmatrelvir/Ritonavir TreatmentAaron F Carlin, Alex E Clark, Antoine Chaillon, et al.
The EMBO Journal|September 18, 2020
Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterolShaobo Wang, Wanyu Li, Hui Hui, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2023
PCIF1-mediated deposition of 5'-cap <i>N</i><sup>6</sup>,2'-<i>O</i>-dimethyladenosine in ACE2 and TMPRSS2 mRNA regulates susceptibility to SARS-CoV-2 infectionLingling Wang, Shaobo Wang, Lujing Wu, et al.
Open Forum Infectious Diseases|April 25, 2023
Neutralizing Antibody Responses After Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 and BA.2.12.1 Infection Do Not Neutralize BA.4 and BA.5 and Can Be Blunted by Nirmatrelvir/Ritonavir TreatmentAaron F Carlin, Alex E Clark, Aaron F Garretson, et al.
Viruses|May 25, 2024
Design and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid Protein to Validate the Viral Quality Assurance PanelsPartha Ray, Melissa Ledgerwood-Lee, Howard Brickner, et al.
Clinical Case Reports|May 3, 2021
Response to pegylated interferon in a COVID-19-positive elderly woman with primary myelofibrosis treated with ruxolitinibArthur E Frankel, Renuka Reddy, Kayla R DeSuza, et al.
Pageof 9